Sample Preparation Market Size to Hit Around USD 14.51 Bn by 2034
The sample preparation market size was exhibited at USD 7.95 billion in 2024 and is projected to hit around USD 14.51 billion by 2034, growing at a CAGR of 6.2% during the forecast period 2024 to 2034.
The Complete Study is Now Available for Immediate Access | Download the Sample Pages of this Report@?https://www.novaoneadvisor.com/report/sample/5826
Sample Preparation Market Key Takeaways:
Sample preparation is the first step in any analytical process. The increasing advancement of technology in the collection and preparation of specimen is anticipated to be the key determinant of growth in the market. For instance, in October 2023, Thorne HealthTech, Inc. collaborated with GenTegra to develop a next-generation collection and extraction kit for whole blood DNA. The partnership will allow companies to develop a new product by integrating GenTegra patented technology of active chemical protection with Thorne’s collection device. This strategy is to the used comparative advantage of both companies to generate high revenue at low costs of R&D.
The market has witnessed a substantial increase in revenue due to the COVID-19 pandemic. Increasing demand for sample preparation in various applications assisted startups in the fundraising process. For instance, in September 2023, two startups, Inso Biosciences, Inc. and Halomine, Inc. announced to receive grants for developing and commercializing solutions for COVID-19 research. The aggregate amount for 18 grants by the New York State Biodefense Commercialization Fund was USD 15.3 million. While Inso Biosciences, a platform developer for genomic sample preparation received USD 955,000.
Similarly, companies are taking the initiative to enhance and maintain the integrity of the specimen for accurate results. For instance, in September 2023, an Australian-based bioanalytical lab, Agilex Biolabs established its first satellite processing lab to support the clinical trials. The lab is expected to conduct time-sensitive sample processing approaches in the same location as clinical trial participants. Hence, this stores the integrity that might decline during the transportation of the specimen. The lab also has expertise in numerous sample preparation techniques, such as whole blood stimulation for cytokine release assays.
Expanding the scope of sample preparation techniques in various types of sequencing is anticipated to drive the growth of the market. The techniques differ according to the type of sequencing being conducted, and the use of technology is considered for sample preparation. For instance, in target sequencing, the requirement of sample input is less as compared to other sequencing types. The key approaches are amplicon sequencing and hybridization capture. The volume of sequencing data is growing, hence driving the requirement for further diverse protocols for sample preparation.
Moreover, in October 2023, 10x Genomics collaborated with Oxford Nanopore Technologies to build a comprehensive sequencing solution for full-length isoform single-cell and spatial sequencing. The collaboration is to allow a streamlined sequencing workflow with integrated sample preparation on highly accessible devices. Hence, the solution is anticipated to improve the result's resolution and process high-yield whole genome sequencing data in hours rather than days.
However, the installation and maintenance of equipment for sample preparation are complex. Along with that, the technology for sample preparation differs depending on the applications, adding further cost and time for the users.
Sample Preparation Market By Product Insights
The consumables segment dominated the market in 2024, with a share of 61.99%, and is expected to witness the fastest growth rate over the forecast period. The consumables are primarily recurring in nature and are less susceptible to the seasonality of the market and industry cycles as compared to instruments. For instance, in May 2023, PacBio announced a 22.16% increase in the consumables revenue from USD 10.4 million in the previous year to USD 12.7 million having a positive impact on segment growth.
The instruments segment is considered to have a stable growth rate during the forecasted period. The purchase frequency of instruments by the End-uses is low owing to a higher lifespan and pricing than consumables. For End-uses, it is essential to incorporate accurate quality instruments to eliminate potential interfering contamination from the sample. For instance, the nucleic acid extraction sample preparation system by Bioteke Corporation is an automated instrument for the extraction process of DNA/RNA.
Sample Preparation Market By Technique Insights
The protein preparation segment dominated the market in 2024, with a share of 45.06%, and is expected to witness the fastest growth rate over the forecast period. The increasing innovation in proteomics is likely to surge the overall market. The extraction process from the sample can result in the loss of proteins by eliminating contaminants and lowering the data reproducibility. In July 2023, researchers from the Babraham Institute advanced the conventional protocols of sample preparation in proteomics by developing a new approach. The technique increases the inclusion of hard to capture cellular proteins, hence improving the readouts of proteomics.
The solid-phase extraction segment accounted for a considerable revenue share in 2021. The expansion of techniques in various fields, such as food and environment, is likely to impact the overall market growth. For instance, in October 2023, Waters Corporation announced to launch Extraction+ connected device that can perform automation preparation of forensics, biological, environmental, and food specimens via solid phase extraction. The solution eliminates the requirement for a manual pipette and extraction of the sample.
Sample Preparation Market By Application Insights
The genomics segment dominated the market in 2024, with a share of 30.94%, and is expected to witness the fastest growth rate over the forecast period. Increasing strategic initiatives by companies in the market for genomics applications are expected to surge the overall growth rate. For instance, in October 2023, Bionano Genomics, Inc. and Hamilton announced the joint development of a product to extract and isolate Ultra High Molecular Weight DNA as the initial part of the sample preparation workflow. The use of long string vantage is in optical genome mapping.
One of the key drivers of this application is expanding the technique for developing personalized treatment through genomics research. For instance, in October 2023, Sight Diagnostics, a technology developer in blood sample preparation, installed its first portable instrument for hematology analysis in the Caribbean. The instrument is installed to offer immediate complete blood count to Tobago and Trinidad patients and assist in diagnosing patients with oncology, critically ill, and pediatrics.
Sample Preparation Market By End Use Insights
The diagnostic center segment dominated the market in 2024, with a share of 41.0%, and is expected to witness the fastest growth rate over the forecast period. The segment in the sample preparation market is estimated to be skewed toward the mature regions, majorly in Western Europe, North America, and Japan. However, increasing spending on human health in emerging markets is likely to drive the market.
Sample Preparation Market By Regional Insights
North America sample preparation market has established global dominance in 2024 with a 41.21% share. The important parament of the largest market share is the presence of well-established suppliers and buyers of the sample preparation solutions in the region. Hence, this speeds up the delivery process from supplier to buyer at a minimal cost. Additionally, increasing accessibility and availability of funds through government and private investors support startup companies to enter the market.?
U.S. Sample Preparation Market Trends
The sample preparation market in the U.S. is primarily driven by advancements in biopharmaceutical research, drug discovery, and clinical diagnostics. The rising demand for personalized medicine, genomics, and proteomics research has fueled the adoption of automated and high-throughput sample preparation systems. Moreover, government initiatives supporting biotechnology and pharmaceutical industries play a pivotal role, coupled with increasing R&D spending in the healthcare sector.
Europe Sample Preparation Market Trends
The sample preparation market in Europe is supported by strong research institutions and pharmaceutical companies. Countries like Germany, France, and the UK are prominent players, benefiting from government-funded research projects and the growing focus on personalized healthcare solutions. Additionally, the rising focus on environmental testing and food safety regulations has further bolstered the demand for advanced sample preparation technologies.
The UK sample preparation market benefits from a robust pharmaceutical and biotechnology sector, driving the need for efficient sample preparation methods. The increasing use of advanced technologies in molecular diagnostics and genomics research, coupled with substantial government funding and collaborative projects between academic institutions and industry players, propels the market growth.
The sample preparation market in France is supported by government initiatives to support research and development in the life sciences sector. The country’s focus on genomic research and the growing importance of personalized medicine contribute to the demand for innovative sample preparation techniques. Additionally, collaborations between pharmaceutical companies and academic institutions boost technological advancements in this market.
Germany sample preparation market is driven by its well-established biotechnology and pharmaceutical industries which has a high demand for automated sample preparation systems in proteomics, genomics, and drug discovery. The country's focus on precision medicine, coupled with its strong R&D infrastructure and government support for healthcare innovation, is a significant market driver.
Asia Pacific Sample Preparation Market Trends
The sample preparation market in Asia Pacific is projected to experience the fastest CAGR in the market. This can be attributed to the increasing adoption of sequencing in China and India for numerous applications, including the development of personalized medicines. Furthermore, the increasing attention to genomics and proteomics research in the Asia Pacific region is anticipated to impact the market with significant growth opportunities during the forecast period.
China sample preparation market is expanding rapidly due to increasing investments in biotechnology, healthcare, and pharmaceutical research. The country’s focus on improving healthcare infrastructure, along with rising demand for molecular diagnostics and genomics, drives the adoption of advanced sample preparation technologies. Government support and growing interest in drug discovery and development further fuel market growth.?
The sample preparation market in Japan is driven by advancements in genomics, proteomics, and personalized medicine. The country’s strong focus on healthcare innovations, combined with significant investment in R&D by pharmaceutical and biotech companies, boosts demand for high-throughput and automated sample preparation systems. Additionally, Japan’s aging population increases the need for advanced diagnostic solutions, which enhances the market.?
India sample preparation market is driven by its growing pharmaceutical and biotechnology industries, alongside increasing investments in healthcare R&D. The rising prevalence of chronic diseases and the growing focus on molecular diagnostics and drug discovery boost the demand for efficient sample preparation techniques. Additionally, government initiatives to improve healthcare infrastructure and boost biopharmaceutical production further support market growth.?
Middle East & Africa Sample Preparation Market Trends
The sample preparation market in the Middle East & Africa is driven by increasing investments in healthcare infrastructure and rising demand for advanced diagnostic tools. The region is focusing on improving clinical research capabilities, with countries like South Africa and UAE playing a crucial role in market growth. The need for efficient sample preparation in diagnostic labs and research centers is rising due to growing disease prevalence.
Saudi Arabia sample preparation market is driven by significant investments in healthcare and clinical research, as the country focuses on developing its biotechnology and pharmaceutical sectors. The growing demand for molecular diagnostics, coupled with the government’s Vision 2030 initiative to modernize healthcare, boosts the need for advanced sample preparation techniques.?
The sample preparation market in Kuwait is driven by increasing healthcare investments and a growing focus on improving diagnostic capabilities. The rising prevalence of chronic diseases, coupled with the country’s efforts to upgrade its healthcare infrastructure, creates a demand for efficient and automated sample preparation technologies in diagnostic and research laboratories.
Some of the prominent players in the sample preparation market include:
Sample Preparation Market Recent Developments
Segments Covered in the Report
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2034. For this study, Nova one advisor, Inc. has segmented the sample preparation market
By Product
By Technique
领英推荐
By Application
By End Use
By Regional
Immediate Delivery Available | Buy This Premium Research https://www.novaoneadvisor.com/report/checkout/5826
Access our Premium Real Time Data Intelligence Tool, Visit: www.precedencestatistics.com
You can place an order or ask any questions, please feel free to [email protected]| +1 9197 992 333
About US
Nova One Advisor is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Nova One Advisor has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.
Connect with Us
Address: Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
IND Address: 707, Nandan Probiz, Baner,?Pune (MH) – 411045, India
USA:?+1 804 441 9344
APAC:?+61 485 981 310 or +91 87933 22019
Europe:?+44 7383 092 044
Email: [email protected]
You can place an order or ask any questions, please feel free to contact at?[email protected] ?| +1 804 441 9344
Nova One Advisor Group Offer Other Reports:
Cell Therapy Market Size and Forecast:?The global?cell therapy market size was exhibited at USD 4.85 billion in 2023 and is projected to hit around USD 37.42 billion by 2033, growing at a CAGR of 22.67% during the forecast period 2024 to 2033.
Gene Therapy Market Size and Forecast?:?The global?gene therapy market size was exhibited at USD 8.75 billion in 2023 and is projected to hit around USD 52.40 billion by 2033, growing at a CAGR of 19.6% during the forecast period 2024 to 2033.
Cell And Gene Therapy Manufacturing Market Size and Forecast:?The global?cell and gene therapy manufacturing market size was estimated at USD 9.95 billion in 2023 and is projected to hit around USD 106.03 billion by 2033, growing at a CAGR of 26.7% during the forecast period from 2024 to 2033.
Cell and Gene Therapy Market?Size and Forecast:?The global?cell and gene therapy market size was estimated at USD 18.13 billion in 2023 and is projected to hit around USD 97.33 billion by 2033, growing at a CAGR of 18.3% during the forecast period from 2024 to 2033.
U.S. Cell Therapy Market Size and Forecast:?The?U.S. cell therapy market size was estimated at USD 2.88 billion in 2023 and is projected to hit around USD 19.67 billion by 2033, growing at a CAGR of 21.18% during the forecast period from 2024 to 2033.
U.S. Gene Therapy Market Size and Forecast:?The?U.S. gene therapy market size?was estimated at USD 3.19 billion in 2023 and is projected to hit around USD 18.50 billion by 2033, growing at a CAGR of 19.22% during the forecast period from 2024 to 2033.
T-cell Therapy Market Size and Forecast:?The global?T-Cell therapy market size?was exhibited at USD 3.85 billion in 2023 and is projected to hit around USD 79.62 billion by 2033, growing at a CAGR of 35.38% during the forecast period 2024 to 2033.
Cancer Immunotherapy Market?Size and Forecast:?The global?cancer immunotherapy market?size was valued at USD 126.19 billion in 2023 and is projected to surpass around USD 296.01 billion by 2033, registering a CAGR of 8.9% over the forecast period of 2024 to 2033.
Immunotherapy Drugs Market?:?The global?immunotherapy drugs market size was valued at USD 240.19 billion in 2023 and is projected to surpass around USD 1,300.38 billion by 2033, registering a CAGR of 18.4% over the forecast period of 2024 to 2033.
Clinical Trials Market Size and Forecast:?The?global clinical trials market size was estimated at USD 81.90 billion in 2023 and is projected to hit around USD 153.59 billion by 2033, growing at a CAGR of 6.49% during the forecast period from 2024 to 2033.
Biologics Market Size and Forecast: The?global biologics market size was estimated at USD 511.04 billion in 2023 and is projected to hit around USD 1,374.51 billion by 2033, growing at a CAGR of 10.4% during the forecast period from 2024 to 2033.
Biotechnology Market Size and Forecast:? The?global biotechnology market size was estimated at USD 1.54 Trillion in 2023 and is projected to hit around USD 5.68 Trillion by 2033, growing at a CAGR of 13.95% during the forecast period from 2024 to 2033.
Oncology? Market Size and Forecast: The?global oncology market size was estimated at USD 222.36 billion in 2023 and is projected to hit around USD 521.60 billion by 2033, growing at a CAGR of 8.9% during the forecast period from 2024 to 2033.
Cell And Gene Therapy Clinical Trials?Market Size and Forecast: The global cell and gene therapy clinical trials market size reached USD 11.62 billion in 2023 and is projected to hit around USD 47.40 billion by 2033, expanding at a CAGR of 15.09% during the forecast period from 2024 to 2033.
U.S. Clinical Trials Market Size and Forecast:?The?U.S. clinical trials market size was valued at USD 25.81 billion in 2023 and is projected to surpass around USD 41.57 billion by 2033, registering a CAGR of 4.88% over the forecast period of 2024 to 2033.
Active Pharmaceutical Ingredient CDMO Market:?The global active pharmaceutical ingredient CDMO market size was valued at USD 119.80 billion in 2023 and is anticipated to reach around USD 249.22 billion by 2033, growing at a CAGR of 7.6% from 2024 to 2033.
U.S. Pharmaceutical Market?:?The U.S. pharmaceutical market size was valued at USD 602.19 billion in 2023 and is projected to surpass around USD 1,093.79 billion by 2033, registering a CAGR of 6.15% over the forecast period of 2024 to 2033.
Viral Vector And Plasmid DNA Manufacturing Market:?The global viral vector and plasmid DNA manufacturing market size?was valued at USD 6.19 billion in 2023 and is anticipated to reach around USD 39.30 billion by 2033, growing at a CAGR of 20.3% from 2024 to 2033.
U.S. Viral Vector And Plasmid DNA Manufacturing Market ;?The U.S. viral vector and plasmid DNA manufacturing market size was valued at USD 2.45 billion in 2023 and is expected to be worth around USD 15.30 billion by 2033, with a registered CAGR of 20.1% during forecast period 2024 to 2033.
Compounding Pharmacies Market :?The global compounding pharmacies market size?was valued at USD 16.19 billion in 2023 and is anticipated to reach around USD 30.97 billion by 2033, growing at a CAGR of 6.7% from 2024 to 2033.
U.S. Compounding Pharmacies Market?:?The U.S. compounding pharmacies market size?is projected to be worth around USD 10.76 billion by 2033 from USD 6.31 billion in 2024, at a CAGR of 6.1% from 2024 to 2033.
Antibiotics Market: The?global antibiotics market size?was valued at USD 51.19 billion in 2023 and is projected to surpass around USD 85.80 billion by 2033, registering a CAGR of 5.3% over the forecast period of 2024 to 2033.
Biologics Market :?The?global biologics market size was estimated at USD 511.04 billion in 2023 and is projected to hit around USD 1,374.51 billion by 2033, growing at a CAGR of 10.4% during the forecast period from 2024 to 2033.
Biotechnology Market:?The?global biotechnology market size was estimated at USD 1.54 Trillion in 2023 and is projected to hit around USD 5.68 Trillion by 2033, growing at a CAGR of 13.95% during the forecast period from 2024 to 2033.
Next Generation Sequencing Market?:?The?global next generation sequencing market size was estimated at USD 9.19 billion in 2023 and is projected to hit around USD 66.04 billion by 2033, growing at a CAGR of 21.8% during the forecast period from 2024 to 2033.
Genome Editing Market ;?The?global genome editing market size?was valued at USD 8.45 billion in 2023 and is anticipated to reach around USD 40.48 billion by 2033, growing at a CAGR of 16.96% from 2024 to 2033.
U.S. Genome Editing Market:?The?U.S. genome editing market size was estimated at USD 3.55 billion in 2023 and is projected to hit around USD 16.49 billion by 2033, growing at a CAGR of 16.6% during the forecast period from 2024 to 2033.
U.S. Gene Synthesis Market?:?The?U.S. Gene Synthesis market size was valued at USD 700.90 million in 2023 and is projected to surpass around USD 3,118.73 million by 2033, registering a CAGR of 16.1% over the forecast period of 2024 to 2033.
Biopharmaceutical Market :?The global?Biopharmaceutical market size accounted for USD 327.46 billion in 2022 and is estimated to achieve a market size of USD 1,101.77 billion by 2032 growing at a CAGR of 12.9% from 2023 to 2032.
Immunotherapy Drugs Market?:?The?global immunotherapy drugs market size was valued at USD 240.19 billion in 2023 and is projected to surpass around USD 1,300.38 billion by 2033, registering a CAGR of 18.4% over the forecast period of 2024 to 2033.
Cancer Immunotherapy Market:?The global cancer immunotherapy market size was valued at USD 126.19 billion in 2023 and is projected to surpass around USD 296.01 billion by 2033, registering a CAGR of 8.9% over the forecast period of 2024 to 2033.
U.S. Plasmid DNA Manufacturing Market?:?The U.S. plasmid DNA manufacturing market size?was valued at USD 711.90 million in 2023 and is projected to surpass around USD 4,885.15 million by 2033, registering a CAGR of 21.24% over the forecast period of 2024 to 2033.
U.S. Precision Medicine Market?:?The?U.S. precision medicine market size was valued at USD 24.95 billion in 2023 and is projected to reach around USD 76.12 billion by 2033, registering a CAGR of 11.80% from 2024 to 2033.